Elanco Animal Health Net Income/Loss 2016-2025 | ELAN
Elanco Animal Health annual/quarterly net income/loss history and growth rate from 2016 to 2025. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
- Elanco Animal Health net income/loss for the quarter ending March 31, 2025 was $67M, a 109.38% increase year-over-year.
- Elanco Animal Health net income/loss for the twelve months ending March 31, 2025 was $733M, a 132.11% decline year-over-year.
- Elanco Animal Health annual net income/loss for 2024 was $0.338B, a 127.46% decline from 2023.
- Elanco Animal Health annual net income/loss for 2023 was $-1.231B, a 1478.21% increase from 2022.
- Elanco Animal Health annual net income/loss for 2022 was $-0.078B, a 83.85% decline from 2021.
| Elanco Animal Health Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2024 | $338 |
| 2023 | $-1,231 |
| 2022 | $-78 |
| 2021 | $-483 |
| 2020 | $-574 |
| 2019 | $68 |
| 2018 | $87 |
| 2017 | $-311 |
| 2016 | $-48 |
| 2015 | $-211 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $6.496B | $4.439B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.898B | 19.61 |
| Encompass Health (EHC) | United States | $12.270B | 26.01 |
| DaVita (DVA) | United States | $11.006B | 15.48 |
| Chemed (CHE) | United States | $8.507B | 26.74 |
| Option Care Health (OPCH) | United States | $5.415B | 24.14 |
| RadNet (RDNT) | United States | $4.514B | 286.48 |
| Amedisys (AMED) | United States | $3.109B | 20.91 |
| LifeStance Health (LFST) | United States | $2.267B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.070B | 22.73 |
| Astrana Health (ASTH) | United States | $1.518B | 37.61 |
| U.S Physical Therapy (USPH) | United States | $1.206B | 31.14 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.122B | 63.89 |
| Pennant (PNTG) | United States | $1.014B | 37.25 |
| Atai Life Sciences (ATAI) | Germany | $0.411B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.037B | 0.00 |
| Daxor (DXR) | United States | $0.037B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |